BSEKabra Drugs LtdMediumNeutral
Announced Fri, 28 Nov · 18:08 IST

Appointment of Secretarial Auditor of the Company

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kabra Drugs Limited has appointed Mrs. Twinkle Agarwal, a Practicing Company Secretary (Membership No. 52868), as the Secretarial Auditor of the company. The appointment is for a five-year term covering financial years 2025-2026 through 2029-2030, effective from 28th November 2025. The appointment has been made to comply with the requirements of the Companies Act, 2013 and SEBI's Listing Regulations. Mrs. Agarwal is a Commerce Graduate from St. Xavier's College and specializes in corporate laws, securities laws, corporate governance, and ROC compliances, with prior experience in secretarial and forensic audits of listed and unlisted companies. The disclosure was signed by Managing Director Nanjappan Aravind, and no director relationships were disclosed in connection with this appointment.

Likely market impact

This is a routine regulatory compliance appointment with no material impact on the company's financials or operations. Shareholders should note this is a standard corporate governance requirement and does not signal any governance concerns or changes in business direction.